by Benzinga Insights | Mar 6, 2026 | General
In the current session, Fortive Inc. (NYSE:FTV) is trading at $55.95, after a 3.59% drop. Over the past month, the stock fell by 6.94%, and in the past year, by 0.88%. With performance like this, long-term shareholders are more likely to start looking into the...
by Nabaparna Bhattacharya | Mar 6, 2026 | General
Reitar Logtech Holdings Limited (NASDAQ:RITR) shares are up on Friday following the announcement of a strategic equity investment agreement worth up to $60 million. Strategic Equity Investment Agreement Under the terms of the agreement, Reitar will issue up to 15...
by Avi Kapoor | Mar 6, 2026 | General
Korn Ferry (NYSE:KFY) will release earnings results for its third quarter, before the opening bell on Monday, March 9. Analysts expect the Los Angeles, California-based company to report quarterly earnings at $1.24 per share, up from $1.19 per share in the year-ago...
by Chris Katje | Mar 6, 2026 | General
Sen. Markwayne Mullin (R-Okla.) could soon have a new title, with the 48-year-old receiving the nomination to replace Kristi Noem as the leader of the Department of Homeland Security by President Donald Trump. Mullin has been flagged for his recent stock trading...
by Benzinga Insights | Mar 6, 2026 | General
AbbVie (NYSE:ABBV) has outperformed the market over the past 10 years by 2.09% on an annualized basis producing an average annual return of 15.03%. Currently, AbbVie has a market capitalization of $407.56 billion. Buying $1000 In ABBV: If an investor had bought $1000...
by Vandana Singh | Mar 6, 2026 | General
BioXcel Therapeutics Inc. (NASDAQ:BTAI) shares are down on Friday. The stock rallied on Thursday after the company shared positive news regarding its drug development. • BioXcel Therapeutics shares are retreating from recent levels. What’s behind BTAI decline? BXCL501...
Recent Comments